Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116400356 | 11640035 | 6 | F | 20160118 | 20160801 | 20151019 | 20160804 | EXP | US-PFIZER INC-2015345580 | PFIZER | 68.00 | YR | F | Y | 95.00000 | KG | 20160804 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116400356 | 11640035 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | UNK, 1X/DAY | 21446 | CAPSULE, HARD | QD | ||||||||
| 116400356 | 11640035 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK, 2X/DAY | 21446 | CAPSULE, HARD | BID | ||||||||
| 116400356 | 11640035 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | 21446 | 100 | MG | CAPSULE, HARD | TID | ||||||
| 116400356 | 11640035 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 1 DF, DAILY | 21446 | 1 | DF | CAPSULE, HARD | |||||||
| 116400356 | 11640035 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK, 3X/DAY; SOMETIMES TAKES AN EXTRA PILL | 21446 | CAPSULE, HARD | TID | ||||||||
| 116400356 | 11640035 | 6 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK, 4X/DAY | 21446 | CAPSULE, HARD | QID | ||||||||
| 116400356 | 11640035 | 7 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 3X/DAY | 21446 | 100 | MG | CAPSULE, HARD | TID | ||||||
| 116400356 | 11640035 | 8 | SS | LYRICA | PREGABALIN | 1 | 100 MG, UNK | 21446 | 100 | MG | CAPSULE, HARD | ||||||||
| 116400356 | 11640035 | 9 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 116400356 | 11640035 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | TABLET | ||||||||||
| 116400356 | 11640035 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116400356 | 11640035 | 1 | Neuropathy peripheral |
| 116400356 | 11640035 | 11 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116400356 | 11640035 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116400356 | 11640035 | Condition aggravated | |
| 116400356 | 11640035 | Intentional product misuse | |
| 116400356 | 11640035 | Myocardial infarction | |
| 116400356 | 11640035 | Pain | |
| 116400356 | 11640035 | Pain in extremity | |
| 116400356 | 11640035 | Peripheral swelling | |
| 116400356 | 11640035 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116400356 | 11640035 | 3 | 2015 | 2015 | 0 | |
| 116400356 | 11640035 | 4 | 201601 | 201604 | 0 |